- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03909542
Malnutrition Associated With Complications After Ileostomy Reversal
April 8, 2019 updated by: Joel Bauer, Icahn School of Medicine at Mount Sinai
Postoperative Complications in Patients With Inflammatory Bowel Disease: A Retrospective Cohort Study
An ileostomy is a surgical opening established by bringing the end or a loop of the ileum to discharge directly outside the body.
This is typically done when part or the entire colon is removed because of IBD, cancer, or familial adenomatous polyposis.
Reversal of this procedure, an ileostomy closure, may be done if possible.
Ileostomy closure involves reconnecting the ileum to the remaining colon, allowing normal bowel movements again.
This study will look at the outcomes of these surgeries in patients who were seen and operated on by the investigators.
Study Overview
Status
Completed
Conditions
Detailed Description
This study focused on outcomes and complications after ileostomy closure.
An ileostomy is a surgical opening established by bringing the end or a loop of the ileum to discharge directly outside the body.
This is typically done when part or the entire colon is removed because of IBD, cancer, or familial adenomatous polyposis.
Reversal of this procedure, an ileostomy closure, may be done if possible to reconnect the ileum to the remaining colon and allow normal bowel movements again.
This study looked at the outcomes for these surgeries in patients who were seen and operated on by the investigators.
Patients were identified from the files and schedules of the investigators, and Epic was used to collect the information needed to determine perioperative clinical characteristics and post-operative outcomes.
This data was kept in a secure electronic database, with identifiers removed as soon as all of the data was collected for a patient.
Study Type
Observational
Enrollment (Actual)
359
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10029
- Icahn School of Medicine at Mount Sinai
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who have had an ileostomy closure procedure
Description
Inclusion Criteria:
- ileostomy closure procedure
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Ileostomy Closure
Patients who have undergone an ileostomy closure procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Complications
Time Frame: up to 5 years
|
Number of any post operative complication
|
up to 5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Joel J Bauer, MD, Icahn School of Medicine at Mount Sinai
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2015
Primary Completion (Actual)
March 5, 2018
Study Completion (Actual)
March 5, 2018
Study Registration Dates
First Submitted
April 8, 2019
First Submitted That Met QC Criteria
April 8, 2019
First Posted (Actual)
April 10, 2019
Study Record Updates
Last Update Posted (Actual)
April 10, 2019
Last Update Submitted That Met QC Criteria
April 8, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GCO 16-0139
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Bowel Diseases
-
Centre Hospitalier Universitaire, AmiensFunding from DGOS (PHRC IR 2013 and PRME)CompletedPediatric Inflammatory Bowel DiseaseFrance
-
University of British ColumbiaCompletedInflammatory Bowel Disease 11Canada
-
University of ChicagoTerminatedInflammatory Bowel Disease (IBD)United States
-
University of Wisconsin, MadisonTerminatedInflammatory Bowel Disease (IBD)United States
-
Cedars-Sinai Medical CenterUnknownPediatric Inflammatory Bowel Disease
-
Assiut UniversityNot yet recruitingIBD-Inflammatory Bowel Disease
-
University of Wisconsin, MadisonCompletedInflammatory Bowel Disease (IBD)United States
-
Icahn School of Medicine at Mount SinaiNorthwestern University; The Cleveland Clinic; University of California, Davis; RxHealt...RecruitingInflammatory Bowel Disease (IBD)United States
-
Nemours Children's ClinicNASPGHAN FoundationCompletedInflammatory Bowel Disease (IBD)United States
-
Hull University Teaching Hospitals NHS TrustWellcome/EPSRC Centre for Interventional and Surgical Sciences, University...RecruitingInflammatory Bowel Disease 1United Kingdom